As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 4/13/21‡ Alexion Pharmaceuticals, Inc.     DEFM14A     4/12/21    1:3.4M                                   Toppan Merrill-FA        
 4/13/21‡ AstraZeneca PLC                   424B3       4/12/21    1:2.9M                                   Toppan Merrill-FA        
  4/9/21  AstraZeneca PLC                   F-4/A                  8:3.4M                                   Toppan Merrill-FA        
 2/19/21  AstraZeneca PLC                   F-4                    7:7.2M                                   Toppan Merrill-FA        
12/14/20  Alexion Pharmaceuticals, Inc.     425                    3:861K Alexion Pharmaceuticals, Inc.     Broadridge Fin’l So… Inc 
12/14/20  Alexion Pharmaceuticals, Inc.     8-K:1,8,9  12/12/20   12:1M                                     Broadridge Fin’l So… Inc 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Types:  -K
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	424B3	Prospectus – New Facts or Events.
	425	Prospectus or Communication – Merger.
	DEFM14A	Definitive Proxy Statement – Merger or Acquisition — Schedule 14A.
	F-4	Registration Statement by a Foreign Issuer – Securities for a Merger — Form F-4.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.